{
 "id": "short-bowel-syndrome",
 "name": "Short bowel syndrome",
 "aliases": [
  "Short bowel syndrome (SBS)"
 ],
 "acronyms": [
  "SBS"
 ],
 "bodySystem": "digestive",
 "parent": null,
 "children": [],
 "edition": "2026-11",
 "merkleRoot": "006ab9a329709cbe7f56a0e1a7c4a02f897655cdfecf9ca34d199690095adcb6",
 "builtFrom": "program.status and program.eligibility facts, grouped by the condition registry",
 "counts": {
  "open": 1,
  "limited": 0,
  "waitlist": 0,
  "closed": 0
 },
 "funds": [
  {
   "fund": "Short bowel syndrome (SBS)",
   "organization": "TotalAssist (Patient Advocate Foundation copay funds)",
   "status": "open",
   "dateOnPage": null,
   "awardLevelUsd": 6000,
   "insuranceTypes": [
    "Any health insurance"
   ],
   "pageSays": "The page lists the fund as Open.",
   "readOn": "2026-11-08",
   "source": "https://totalassist.org/funds/"
  }
 ],
 "drugsWhoseLabelNamesThisCondition": [
  {
   "ingredient": "Teduglutide",
   "pages": [
    {
     "brand": "Gattex",
     "url": "https://omnirx.org/medicines/gattex"
    }
   ],
   "labelSentence": "GATTEX ® is indicated for the treatment of adults and pediatric patients 1 year of age and older with Short Bowel Syndrome (SBS) who are dependent on parenteral support .",
   "labelContext": "indication",
   "labelSource": "https://api.fda.gov/drug/label.json?search=set_id:%2266b69c1e-b25c-44d3-b5ff-1c1de9a516fa%22&limit=1",
   "labelRead": "2026-11-10",
   "manufacturerPrograms": [],
   "medicareNegotiatedPrice": null
  }
 ],
 "fundsForRelatedCosts": [],
 "note": "Each status is what the fund page said on readOn. It is not an eligibility determination. We hold only the organizations we read; no fund here does not mean no fund exists.",
 "licence": "CC BY 4.0 for the OmniRx compilation"
}